XR
XRF.AU XRF Scientific Ltd
- Market cap
- AUD 307M
- P/E
- 30.3x
- P/B
- 4.62x
- ROE
- 15.8%
- Dividend yield
- 1.64%
- Fundamental score
- 2.9/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is XRF.AU undervalued?
Graham numberXRF.AU trades 149.3% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
XRF Scientific Ltd fundamental analysis
14 of 22 checks passedROE 1/2
Moderate return on equity (15.8%), between 10% and 20%.
ROA 1/1
Return on assets (13.3%) is above the industry median (2.4%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-2.1%) is not above the 5-year average (13.7% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-2.1%) is below the industry median (-2.1%).
Revenue Growth 1/2
Revenue grew 5.1% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (3.5%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 129.5x against interest expense, well covered.
PE vs Market 0/1
PE (30.3x) is above the market median (15.0x).
PE vs Industry 0/1
PE (30.3x) is above the industry median (15.0x).
PBV 0/1
Price to book (4.6x) is above the industry median (1.6x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 139.9, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 2.21, above 1.
Dividend Yield 0/2
Dividend yield (1.6%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 1/2
Dividends paid without a cut of more than 10% for 9 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 47.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
XRF Scientific Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About XRF Scientific Ltd
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufact…
Full company profileXRF Scientific Ltd financial statements
XRF Scientific Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 21.5M | 24.3M | 29.0M | 29.1M | 31.3M | 40.0M | 55.2M | 59.8M | 59.4M | 64.1M |
| Gross Profit | 8.88M | 9.65M | 11.4M | 11.3M | 12.9M | 16.5M | 22.0M | 26.3M | 28.8M | 30.1M |
| Operating Income | 1.27M | 1.76M | 3.33M | 4.84M | 6.38M | 8.79M | 12.8M | 14.5M | 15.8M | 17.0M |
| EBITDA | 1.78M | 2.46M | 4.11M | 5.86M | 8.05M | 9.44M | 13.2M | 15.3M | 16.5M | 18.7M |
| Net Income | 794K | 1.02M | 2.14M | 3.12M | 5.13M | 6.08M | 7.69M | 8.89M | 10.4M | 10.5M |
| EPS | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.04 | 0.06 | 0.06 | 0.07 | 0.07 |
| Balance Sheet | ||||||||||
| Total Assets | 34.7M | 37.9M | 41.7M | 45.2M | 48.4M | 55.6M | 65.5M | 68.2M | 72.8M | 78.7M |
| Total Liabilities | 3.95M | 6.21M | 7.91M | 9.53M | 9.27M | 12.2M | 16.0M | 12.7M | 12.6M | 12.3M |
| Shareholders' Equity | 30.8M | 31.7M | 33.8M | 35.6M | 39.1M | 43.5M | 49.3M | 54.9M | 60.2M | 66.4M |
| Cash & Short-term Investments | 833K | 415K | 3.24M | 3.63M | 5.26M | 6.65M | 10.4M | 12.0M | 12.2M | 9.46M |
| Total Debt | 1.25M | 2.27M | 2.26M | 1.94M | 1.44M | 3.51M | 4.31M | 3.38M | 4.41M | 2.34M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 156K | 808K | 3.88M | 4.20M | 4.51M | 3.15M | 8.42M | 8.09M | 10.1M | 11.4M |
| Capital Expenditure | 1.84M | 1.70M | 521K | 753K | 653K | 519K | 782K | 1.64M | 1.75M | 1.70M |
| Free Cash Flow | -1.69M | -894K | 3.36M | 3.45M | 3.86M | 2.63M | 7.63M | 6.45M | 8.39M | 9.69M |
| Ratios | ||||||||||
| ROE | 2.6% | 3.2% | 6.3% | 8.8% | 13.1% | 14.0% | 15.6% | 16.2% | 17.3% | 15.8% |
| ROA | 2.3% | 2.7% | 5.1% | 6.9% | 10.6% | 11.0% | 11.7% | 13.0% | 14.3% | 13.3% |
| Net Profit Margin | 3.7% | 4.2% | 7.4% | 10.7% | 16.4% | 15.2% | 13.9% | 14.8% | 17.5% | 16.4% |
| Debt to Equity | 0.04x | 0.07x | 0.07x | 0.05x | 0.04x | 0.08x | 0.09x | 0.06x | 0.07x | 0.04x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
XRF Scientific Ltd dividends
- Dividend yield
- 1.64%
- Forward dividend
- 0.05 AUD
- Payout ratio
- 47.8%
- Ex-dividend date
- Sep 10, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | AUD 5.02M | 0.03 | 47.8% |
| 2025 | AUD 4.52M | 0.03 | 43.5% |
| 2024 | AUD 3.60M | 0.03 | 40.5% |
| 2023 | AUD 2.68M | 0.02 | 34.9% |
| 2022 | AUD 2.13M | 0.02 | 34.9% |
| 2021 | AUD 1.65M | 0.01 | 32.2% |
| 2020 | AUD 1.34M | 0.01 | 42.9% |
| 2019 | AUD 401K | 0.00 | 18.8% |
| 2018 | AUD 321K | 0.00 | 31.4% |
| 2017 | AUD 401K | 0.00 | 50.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.1343:1 on Oct 12, 2007.
Who owns XRF Scientific Ltd
- Insiders 29.90%
- Institutions 5.96%
- Public & others 64.14%
- Shares outstanding 145M
- Free float 102M
XRF Scientific Ltd company profile
- Company name
- XRF Scientific Ltd
- Ticker
- XRF.AU
- ISIN
- AU000000XRF8
- Exchange
- Australian Securities Exchange
- Listed since
- Oct 31, 2006
- Sector
- Industrials
- Industry
- Machinery
- Fiscal year end
- June
- Address
- 86 Guthrie Street, Osborne Park, WA, Australia, 6017
- Phone
- 61 8 9244 0600
- Website
- xrfscientific.com
About XRF Scientific Ltd
XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction materials, chemicals, petrochemicals, and metals and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instruments. Its Precious Metals segment manufactures products for the laboratory and industrial platinum alloy markets. The Consumables segment manufactures chemicals and other supplies for analytical laboratories. It also provides electric and gas fusion machines, flux weighing, fusion flux, and fusion labware products; reference materials, including drift monitors, fused calibration beads, and synthetic iron ore; pressing consumables and xrTab binder tablets; zirconium crucibles; laboratory jaw crushers and containerised laboratories; press and pellet press dies; water dispensing systems; platinum beakers, crucibles, and dishes; and platinum products, such as electrodes, ICP components, customised platinum components, and semi-finished products. In addition, the company offers instruments comprising thermogravimetric analysis; CGA elemental analysers; pH, conductivity, and acid base titration; and weighing systems, as well as product recycling services. XRF Scientific Limited was founded in 1972 and is based in Osborne Park, Australia.
XRF Scientific Ltd management
2- Mr. Vance Stazzonelli B.Comm, CPAMD, Company Secretary & Executive Director
- Mr. Andrew Watson B.Comm, CACFO & Joint Company Secretary